AN OPEN-LABEL, SINGLE-TREATMENT, SINGLE-PERIOD, SINGLE DOSE, PHASE 1 CLINICAL STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF DIPHTHERIA, TETANUS AND PERTUSSIS (WHOLE CELL) VACCINE OF M/s CADILA HEALTHCARE LTD., INDIA IN HEALTHY, ADULT, MALE, HUMAN SUBJECTS
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Diphtheria tetanus and pertussis vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors Cadila Healthcare
- 19 Feb 2014 New trial record